Artificial intelligence-generated synthetic data for cancer research and clinical trials

Area of Science:

• Medical Informatics
• Artificial Intelligence in Healthcare
• Biostatistics

Background:

• Synthetic data, generated using artificial intelligence (AI), is increasingly used in medical research.
• It replicates real-world data properties, offering alternatives to conventional datasets.
• Applications are notable in high-stakes fields like hematology and oncology.

Purpose of the Study:

• To review the role and impact of synthetic data in cancer research and clinical trials.
• To examine the potential benefits, limitations, and challenges of synthetic data.
• To propose best practices for enhancing the quality and utility of synthetic data.

Main Methods:

• Review of current literature and real-world applications of synthetic data in healthcare.
• Critical analysis of challenges including standardization, bias, privacy, and quality assurance.
• Development of recommendations for best practices in synthetic data generation and application.

Main Results:

• Synthetic data can supplement or substitute real-world data, overcoming access barriers and potentially reducing clinical trial costs.
• Significant challenges remain in standardization, evaluation, bias mitigation, privacy, and quality assurance.
• Despite limitations, synthetic data holds potential to improve data sharing, collaboration, and trial design.

Conclusions:

• Synthetic data is a promising tool for healthcare research but not a universal solution.
• Rigorous validation and oversight are essential for its reliable and safe application.
• With proper implementation, synthetic data can significantly advance cancer research and clinical trial methodologies.